Santa Cruz Biotechnology offers a broad range of RuvA monoclonal antibodies for advanced research in molecular biology and biochemistry. RuvA monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RuvA plays a crucial role in DNA repair processes, specifically in resolving Holliday junctions during homologous recombination. RuvA functions are vital for maintaining genomic stability and facilitating proper DNA replication, making it an important target for studies related to cancer and genetic disorders. Understanding RuvA can provide insights into DNA repair mechanisms and their implications in various diseases. Researchers worldwide rely on RuvA monoclonal antibodies to advance their studies in DNA repair pathways. Investigating RuvA helps illuminate the complex relationship between DNA damage and disease progression. RuvA research contributes to developing new therapeutic strategies for genetic disorders. Santa Cruz Biotechnology monoclonal antibodies for RuvA support researchers in making meaningful discoveries that advance our understanding of DNA repair mechanisms and their impact on human health.